Annotation Detail for EGFL7

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C075773 |
4-phenylbutyric acid |
4-phenylbutyric acid results in increased expression of EGFL7 mRNA alternative form | increases expression | 19116145
|
C075773 |
4-phenylbutyric acid |
[decitabine co-treated with 4-phenylbutyric acid] results in increased expression of EGFL7 mRNA alternative form | affects cotreatment|increases expression | 19116145
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of EGFL7 mRNA | affects expression | 16483693
|
C014347 |
decitabine |
[decitabine co-treated with 4-phenylbutyric acid] results in increased expression of EGFL7 mRNA alternative form | affects cotreatment|increases expression | 19116145
|
C014347 |
decitabine |
decitabine results in increased expression of EGFL7 mRNA alternative form | increases expression | 19116145
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of EGFL7 mRNA | increases expression | 18042831
|
C041786 |
palm oil |
palm oil results in increased expression of EGFL7 mRNA | increases expression | 18042831
|
C025643 |
vinclozolin |
vinclozolin affects the expression of EGFL7 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.89 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.31 | 15238619 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.28 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.28 | 20435547 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.66 | 19215824 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.72 | 14966744 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.67 | 18367378 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.64 | 19294695 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.56 | 19551842 17967931 18296743 19004024 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
3.94 | 18296743 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.40 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.82 | 16417039 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.69 | 19215824 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.92 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.97 | 21332399 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.60 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.60 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.57 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.30 | 11836018 18457598 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.21 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.33 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.42 | 19010910 18704418 17679729 18206229 18460780 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.98 | 18055864 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.19 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.03 | 18296743 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.64 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.56 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.54 | 16882708 18608210 19157545 19010910 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
6.13 | 19116145 |
MESH:D009369 |
Neoplasms |
|
decitabine |
6.13 | 17925555 19116145 19470736 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.34 | 18457598 19632207 16723640 17217161 20132043 21332399 20518802 18674790 11836018 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.72 | 19259094 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.85 | 19294695 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.36 | 18042343 18220299 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.15 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.40 | 18220299 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.40 | 18629315 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.75 | 19155313 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.57 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.82 | 19087683 17616700 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.43 | 17785578 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.02 | 16723640 |